2021-16408. Medical Device User Fee Rates for Fiscal Year 2022  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing the fee rates and payment procedures for medical device user fees for fiscal year (FY) 2022. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Medical Device User Fee Amendments of 2017 (MDUFA IV), authorizes FDA to collect user fees for certain medical device submissions and annual fees both for certain periodic reports and for establishments subject to registration. This notice establishes the fee rates for FY 2022, which apply from October 1, 2021, through September 30, 2022, and provides information on how the fees for FY 2022 were determined, the payment procedures you should follow, and how you may qualify for reduced small business fees.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    For information on Medical Device User Fees: https://www.fda.gov/​industry/​fda-user-fee-programs/​medical-device-user-fee-amendments-mdufa.

    For questions relating to the MDUFA Small Business Program, please visit the Center for Devices and Radiological Health's website: https://www.fda.gov/​medical-devices/​premarket-submissions/​reduced-medical-device-user-fees-small-business-determination-sbd-program.

    For questions relating to this notice: Andrew Bank, Office of Financial Management, Food and Drug Administration, 4041 Powder Mill Rd., Rm. 62019A, Beltsville, MD 20705, 301-796-0292.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    I. Background

    Section 738 of the FD&C Act (21 U.S.C. 379j) establishes fees for certain medical device applications, submissions, supplements, notices, and requests (for simplicity, this document refers to these collectively as “submissions” or “applications”); for periodic reporting on class III devices; and for the registration of certain establishments. Under statutorily defined conditions, a qualified applicant may receive a fee waiver or may pay a lower small business fee (see 21 U.S.C. 379j(d) and (e)).

    Under the FD&C Act, the fee rate for each type of submission is set at a specified percentage of the standard fee for a premarket application (a premarket application is a premarket approval application (PMA), a product development protocol (PDP), or a biologics license application (BLA)). The FD&C Act specifies the base fee for a premarket application for each year from FY 2018 through FY 2022; the base fee for a premarket application received by FDA during FY 2022 is $329,000. From this starting point, this document establishes FY 2022 fee rates for certain types of submissions, and for periodic reporting, by applying criteria specified in the FD&C Act.

    The FD&C Act specifies the base fee for establishment registration for each year from FY 2018 through FY 2022; the base fee for an establishment registration in FY 2022 is $4,978. There is no reduction in the registration fee for small businesses. Each establishment that is registered (or is required to register) with the Secretary of Health and Human Services under section 510 of the FD&C Act (21 U.S.C. 360) because such establishment is engaged in the manufacture, preparation, propagation, compounding, or processing of a device is required to pay the annual fee for establishment registration.

    II. Revenue Amount for FY 2022

    The total revenue amount for FY 2022 is $213,687,660, as set forth in the statute prior to the inflation adjustment (see 21 U.S.C. 379j(b)(3)). MDUFA directs FDA to use the yearly total revenue amount as a starting point to set the standard fee rates for each fee type. The fee calculations for FY 2022 are described in this document.

    Inflation Adjustment

    MDUFA specifies that the $213,687,660 is to be adjusted for inflation increases for FY 2022 using two separate adjustments—one for payroll costs and one for non-payroll costs (see 21 U.S.C. 379j(c)(2)). The base inflation adjustment for FY 2022 is the sum of one plus the two separate adjustments and is compounded as specified in the statute (see 21 U.S.C. 379j(c)(2)(C) and 379j(c)(2)(B)).

    The component of the inflation adjustment for payroll costs is the average annual percent change in the cost of all personnel compensation and benefits (PC&B) paid per full-time equivalent position (FTE) at FDA for the first 3 of the 4 preceding FYs, multiplied by 0.60, or 60 percent (see 21 U.S.C. 379j(c)(2)(C)).

    Table 1 summarizes the actual cost and FTE data for the specified FYs, and provides the percent change from the previous FY and the average percent change over the first 3 of the 4 FYs preceding FY 2022. The 3-year average is 2.7383 percent (rounded).Start Printed Page 41478

    Table 1—FDA PC&Bs Each Year and Percent Change

    Fiscal year2018201920203-Year average
    Total PC&B$2,690,678,000$2,620,052,000$2,875,592,000
    Total FTE17,02317,14417,535
    PC&B per FTE$158,061$152,826$163,992
    Percent change from previous year4.2206%−3.3120%7.3063%2.7383%

    The payroll adjustment is 2.7383 percent multiplied by 60 percent, or 1.6430 percent. The statute specifies that the component of the inflation adjustment for non-payroll costs for FY 2022 is the average annual percent change that occurred in the Consumer Price Index (CPI) for urban consumers (Washington-Baltimore, DC-MD-VA-WV; Not Seasonally Adjusted; All Items; Annual Index) for the first 3 of the preceding 4 years of available data multiplied by 0.40, or 40 percent (see 21 U.S.C. 379j(c)(2)(C)). As a result of a geographical revision made by the Bureau of Labor and Statistics in January 2018,[1] the “Washington-Baltimore, DC-MD-VA-WV” index was discontinued and replaced with two separate indices (i.e., “Washington-Arlington-Alexandria, DC-VA-MD-WV” and “Baltimore-Columbia-Towson, MD”). In order to continue applying a CPI that best reflects the geographic region in which FDA is headquartered and that provides the most current data available, the Washington-Arlington-Alexandria index has been used since FY 2020 and will be used in calculating the relevant adjustment factors for FY 2022 and subsequent years.

    Table 2 provides the summary data and the 3-year average percent change in the specified CPI for the Washington-Arlington-Alexandria area. These data are published by the Bureau of Labor Statistics and can be found on their website under series Id CUURS35ASA0 at: https://data.bls.gov/​pdq/​SurveyOutputServlet?​data_​tool=​dropmap&​series_​id=​CUURS35ASA0,CUUSS35ASA0.

    Table 2—Annual and 3-Year Average Percent Change in Washington-Arlington-Alexandria Area CPI

    Fiscal year2018201920203-Year average
    Annual CPI261.445264.777267.157
    Annual Percent Change2.0389%1.2745%0.8989%
    3-Year Average Percent Change in CPI1.4041%

    The non-payroll adjustment is 1.4041 percent multiplied by 40 percent, or 0.5616 percent. Next, the payroll adjustment (1.6430 percent or 0.016430) is added to the non-payroll adjustment (0.5616 percent or .005616), for a total of 2.2046 percent (or 0.022046). To complete the inflation adjustment, 1 (100 percent or 1.0) is added for a total base inflation adjustment of 1.022046 for FY 2022.

    MDUFA IV provides for this inflation adjustment to be compounded for FY 2022 and each subsequent fiscal year (see 21 U.S.C. 379j(c)(2)(B)(ii)). To complete the compounded inflation adjustment for FY 2022, the FY 2021 compounded adjustment (1.114808) is multiplied by the FY 2022 base inflation adjustment (1.022046) to reach the applicable inflation adjustment of 1.139385 (rounded) for FY 2022. We then multiply the total revenue amount for FY 2022 ($213,687,660) by 1.139385, yielding an inflation adjusted total revenue amount of $243,473,000 (rounded to the nearest thousand dollars).

    III. Fees for FY 2022

    Under the FD&C Act, all submission fees and the periodic reporting fee are set as a percent of the standard (full) fee for a premarket application (see 21 U.S.C. 379j(a)(2)(A)).

    A. Inflation Adjustment

    MDUFA specifies that the base fees of $329,000 (premarket application) and $4,978 (establishment registration) are to be adjusted for FY 2022 using the same methodology as that for the total revenue inflation adjustment in section II (see 21 U.S.C. 379j(c)(2)(D)(i)). Multiplying the base fees by the compounded inflation adjustment of 1.139385 yields inflation adjusted base fees of $374,858 (premarket application) and $5,672 (establishment registration).

    B. Further Adjustments

    After the applicable inflation adjustment to fees is done, FDA may increase, if necessary to achieve the inflation adjusted total revenue amount, the base fee amounts on a uniform proportionate basis (see 21 U.S.C. 379j(c)(2)(D)(ii)). If necessary, after this adjustment, FDA may further increase the base establishment registration fees to generate the inflation adjusted total revenue amount (see 21 U.S.C. 379j(c)(3)).

    C. Calculation of Fee Rates

    Table 3 provides the last 3 years of fee-paying submission counts and the 3-year average. These numbers are used to project the fee-paying submission counts that FDA will receive in FY 2022.

    Table 3—Three-Year Average of Fee-Paying Submissions

    Application typeFY 2018 actualFY 2019 actualFY 2020 actual3-Year average
    Full Fee Applications38323033
    Small Business7867
    Panel-Track Supplement23142220
    Start Printed Page 41479
    Small Business5465
    De Novo Classification Request27121117
    Small Business29371828
    180-Day Supplements133124126128
    Small Business27232124
    Real-Time Supplements169213175186
    Small Business34432935
    510(k)s2,1222,0692,0492,080
    Small Business1,3851,5581,6671,537
    30-Day Notice1,058925867950
    Small Business98111105105
    513(g) (21 U.S.C. 360c(g)) Request for Classification Information84759685
    Small Business33545748
    Annual Fee for Periodic Reporting624629420558
    Small Business 274966879
    Establishment Registration27,54427,73441,40932,229

    The information in table 3 is necessary to estimate the amount of revenue that will be collected based on the fee amounts. Table 4 displays the FY 2022 base fees set in statute (column one) and the inflation adjusted base fees (per calculations in section III.A.) (column two). Using the inflation adjusted fees and the 3-year averages of fee-paying submissions, collections are projected to total $262,694,460, which is $19,221,460 higher than the inflation adjusted total revenue amount (in section II). The fees in column two are those we are establishing in FY 2022, which are the standard fees.

    Table 4—Fees Needed To Achieve New FY 2022 Revenue Target

    Application typeFY 2022 statutory fees (base fees)FY 2022 Inflation adjusted statutory base fees (standard fees)3-Year average of fee-paying submissionsFY 2022 revenue from adjusted fees
    Full Fee Applications$329,000$374,85833$12,370,303
    Small Business82,25093,7147656,001
    Panel-Track Supplement246,750281,143205,622,865
    Small Business61,68870,2865351,429
    De Novo Classification Request98,700112,457171,911,774
    Small Business24,67528,11428787,201
    180-Day Supplements49,35056,2291287,197,267
    Small Business12,33814,05724337,372
    Real-Time Supplements23,03026,2401864,880,647
    Small Business5,7586,56035229,600
    510(k)s11,18612,7452,08026,509,934
    Small Business2,7973,1861,5374,897,328
    30-Day Notice5,2645,9989505,697,837
    Small Business2,6322,999105314,880
    513(g) Request for Classification Information4,4425,06185430,149
    Small Business2,2212,53048121,454
    Annual Fee for Periodic Reporting11,51513,1205587,320,970
    Small Business2,8793,28079259,120
    Establishment Registration4,9785,67232,229182,798,329
    Total262,694,460

    The standard fee (adjusted base amount) for a premarket application, including a BLA, and for a premarket report and a BLA efficacy supplement, is $374,858 for FY 2022. The fees set by reference to the standard fee for a premarket application are:

    • For a panel-track supplement, 75 percent of the standard fee;
    • For a de novo classification request, 30 percent of the standard fee;
    • For a 180-day supplement, 15 percent of the standard fee;
    • For a real-time supplement, 7 percent of the standard fee;
    • For an annual fee for periodic reporting concerning a class III device, 3.5 percent of the standard fee;
    • For a 510(k) premarket notification, 3.4 percent of the standard fee;
    • For a 30-day notice, 1.6 percent of the standard fee; and
    • For a 513(g) request for classification information, 1.35 percent of the standard fee.

    For all submissions other than a 30-day notice and a 513(g) request for classification information, the small business fee is 25 percent of the standard (full) fee for the submission (see 21 U.S.C. 379j(d)(2)(C) and (e)(2)(C)). For a 30-day notice and a 513(g) request for classification information, the small business fee is 50 Start Printed Page 41480percent of the standard (full) fee for the submission (see 21 U.S.C. 379j(d)(2)(C)).

    The annual fee for establishment registration, after adjustment, is set at $5,672 for FY 2022. There is no small business rate for the annual establishment registration fee; all establishments pay the same fee.

    Table 5 summarizes the FY 2022 rates for all medical device fees.

    Table 5—Medical Device Fees for FY 2022

    Application fee typeStandard fee (as a percent of the standard fee for a premarket application)FY 2022 standard feeFY 2022 small business fee
    Premarket application (a PMA submitted under section 515(c)(1) of the FD&C Act (21 U.S.C. 360e(c)(1)), a PDP submitted under section 515(f) of the FD&C Act, or a BLA submitted under section 351 of the Public Health Service Act (the PHS Act) (42 U.S.C. 262))Base fee specified in statute$374,858$93,714
    Premarket report (submitted under section 515(c)(2) of the FD&C Act)100374,85893,714
    Efficacy supplement (to an approved BLA under section 351 of the PHS Act)100374,85893,714
    Panel-track supplement75281,14370,286
    De novo classification request30112,45728,114
    180-day supplement1556,22914,057
    Real-time supplement726,2406,560
    510(k) premarket notification submission3.4012,7453,186
    30-day notice1.605,9982,999
    513(g) request for classification information1.355,0612,530
    Annual Fee Type
    Annual fee for periodic reporting on a class III device3.5013,1203,280
    Annual establishment registration fee (to be paid by the establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device, as defined by 21 U.S.C. 379i(14))Base fee specified in statute5,6725,672

    IV. How To Qualify as a Small Business for Purposes of Medical Device Fees

    If your business, including your affiliates, has gross receipts or sales of no more than $100 million for the most recent tax year, you may qualify for reduced small business fees. If your business, including your affiliates, has gross sales or receipts of no more than $30 million, you may also qualify for a waiver of the fee for your first premarket application (i.e. PMA, PDP, or BLA) or premarket report. If you want to pay the small business fee rate for a submission or you want to receive a waiver of the fee for your first premarket application or premarket report, you should submit the materials showing you qualify as a small business at least 60 days before you send your submission to FDA. Please note that the establishment registration fee is not eligible for a reduced small business fee. As a result, if the establishment registration fee is the only medical device user fee that you will pay in FY 2022, you should not submit a Small Business Certification Request. FDA will review your information and determine whether you qualify as a small business eligible for the reduced fee and/or fee waiver. If you make a submission before FDA finds that you qualify as a small business, you must pay the standard (full) fee for that submission.

    If your business qualified as a small business for FY 2021, your status as a small business will expire at the close of business on September 30, 2021. You must re-qualify for FY 2022 in order to pay small business fees during FY 2022.

    A. Domestic (U.S.) Businesses

    If you are a domestic (U.S.) business and wish to qualify as a small business for FY 2022, submit the following to FDA:

    1. A completed MDUFA Small Business Certification Request For a Business Headquartered in the United States (Form FDA 3602). Form FDA 3602 is provided in the FDA Forms database: https://www.fda.gov/​downloads/​AboutFDA/​ReportsManualsForms/​Forms/​UCM573420.pdf.

    2. A signed copy of your Federal (U.S.) Income Tax Return for the most recent tax year. The most recent tax year will be 2021, except:

    If you submit your MDUFA Small Business Certification Request for FY 2022 before April 15, 2022, and you have not yet filed your return for 2021, you may use tax year 2020.

    If you submit your MDUFA Small Business Certification Request for FY 2022 on or after April 15, 2022, and have not yet filed your 2021 return because you obtained an extension, you may submit your most recent return filed prior to the extension.

    3. For each of your affiliates, either:

    • If the affiliate is a domestic (U.S.) business, a signed copy of the affiliate's Federal (U.S.) Income Tax Return for the most recent tax year, or
    • If the affiliate is a foreign business and cannot submit a Federal (U.S.) Income Tax Return, a National Taxing Authority Certification completed by, and bearing the official seal of, the National Taxing Authority of the country in which the firm is headquartered. The National Taxing Authority is the foreign equivalent of the U.S. Internal Revenue Service. This certification must show the amount of gross receipts or sales for the most recent tax year, in both U.S. dollars and the local currency of the country, the exchange rate used in converting the local currency to U.S. dollars, and the dates of the gross receipts or sales collected. The business must also submit a statement signed by the head of the business's firm or by its chief financial officer that the business has submitted certifications for all of its affiliates, identifying the name of each affiliate, or that the business has no affiliates.

    B. Foreign Businesses

    If you are a foreign business, and wish to qualify as a small business for FY 2022, submit the following:

    1. A completed MDUFA Foreign Small Business Certification Request For a Business Headquartered Outside the United States (Form FDA 3602A). Form FDA 3602A is provided in the FDA Forms database: https://www.fda.gov/​downloads/​AboutFDA/​ReportsManualsForms/​Forms/​UCM573423.pdf. Start Printed Page 41481

    2. A National Taxing Authority Certification, completed by, and bearing the official seal of, the National Taxing Authority of the country in which the firm is headquartered. This certification must show the amount of gross receipts or sales for the most recent tax year, in both U.S. dollars and the local currency of the country, the exchange rate used in converting the local currency to U.S. dollars, and the dates of the gross receipts or sales collected.

    3. For each of your affiliates, either:

    • If the affiliate is a domestic (U.S.) business, a signed copy of the affiliate's Federal (U.S.) Income Tax Return for the most recent tax year (2021 or later), or
    • If the affiliate is a foreign business and cannot submit a Federal (U.S.) Income Tax Return, a National Taxing Authority Certification completed by, and bearing the official seal of, the National Taxing Authority of the country in which the firm is headquartered. The National Taxing Authority is the foreign equivalent of the U.S. Internal Revenue Service. This certification must show the amount of gross receipts or sales for the most recent tax year, in both U.S. dollars and the local currency of the country, the exchange rate used in converting the local currency to U.S. dollars, and the dates for the gross receipts or sales collected. The business must also submit a statement signed by the head of the business's firm or by its chief financial officer that the applicant has submitted certifications for all of its affiliates, identifying the name of each affiliate, or that the business has no affiliates.

    V. Procedures for Paying Application Fees

    If your application or submission is subject to a fee and your payment is received by FDA between October 1, 2021, and September 30, 2022, you must pay the fee in effect for FY 2022. To avoid delay in the review of your application, you should pay the application fee before or at the time you submit your application to FDA. The later of the date that the application is received in the reviewing center's document room or the date the U.S. Treasury recognizes the payment determines whether the fee rates for FY 2021 or FY 2022 apply. FDA must receive the correct fee at the time that an application is submitted, or the application will not be accepted for filing or review.

    FDA requests that you follow the steps below before submitting a medical device application subject to a fee to ensure that FDA links the fee with the correct application. (Note: Do not send your user fee check to FDA with the application.)

    A. Secure a Payment Identification Number (PIN) and Medical Device User Fee Cover Sheet From FDA Before Submitting Either the Application or the Payment

    Log into the User Fee System at: https://userfees.fda.gov/​OA_​HTML/​mdufmaCAcdLogin.jsp. Complete the Medical Device User Fee cover sheet. Be sure you choose the correct application submission date range. (Two choices will be offered until October 1, 2021. One choice is for applications and fees that will be received on or before September 30, 2021, which are subject to FY 2021 fee rates. A second choice is for applications and fees received on or after October 1, 2021, which are subject to FY 2022 fee rates.) After completing data entry, print a copy of the Medical Device User Fee cover sheet and note the unique PIN located in the upper right-hand corner of the printed cover sheet.

    B. Electronically Transmit a Copy of the Printed Cover Sheet With the PIN

    When you are satisfied that the data on the cover sheet is accurate, electronically transmit that data to FDA according to instructions on the screen. Applicants are required to set up a user account and password to assure data security in the creation and electronic submission of cover sheets.

    C. Submit Payment for the Completed Medical Device User Fee Cover Sheet

    1. The preferred payment method is online using electronic check (Automated Clearing House (ACH) also known as eCheck) or credit card (Discover, VISA, MasterCard, American Express). FDA has partnered with the U.S. Department of the Treasury to utilize Pay.gov, a web-based payment system, for online electronic payment. You may make a payment via electronic check or credit card after submitting your cover sheet. Secure electronic payments can be submitted using the User Fees Payment Portal at https://userfees.fda.gov/​pay. Note: only full payments are accepted. No partial payments can be made online. Once you search for your invoice, select “Pay Now” to be redirected to Pay.gov. Electronic payment options are based on the balance due. Payment by credit card is available for balances that are less than $25,000. If the balance exceeds this amount, only the ACH option is available. Payments must be made using U.S bank accounts as well as U.S. credit cards.

    2. If paying with a paper check:

    • All paper checks must be in U.S. currency from a U.S. bank and made payable to the Food and Drug Administration. If needed, FDA's tax identification number is 53-0196965.
    • Please write your application's unique PIN (from the upper right-hand corner of your completed Medical Device User Fee cover sheet) on your check.
    • Mail the paper check and a copy of the completed cover sheet to: Food and Drug Administration, P.O. Box 979033, St. Louis, MO 63197-9000. (Please note that this address is for payments of application and annual report fees only and is not to be used for payment of annual establishment registration fees.)

    If you prefer to send a check by a courier, the courier may deliver the check to: U.S. Bank, Attn: Government Lockbox 979033, 1005 Convention Plaza, St. Louis, MO 63101. (Note: This U.S. Bank address is for courier delivery only. If you have any questions concerning courier delivery contact U.S. Bank at 314-418-4013. This telephone number is only for questions about courier delivery.)

    3. If paying with a wire transfer:

    • Please include your application's unique PIN (from the upper right-hand corner of your completed Medical Device User Fee cover sheet) in your wire transfer. Without the PIN, your payment may not be applied to your cover sheet and review of your application may be delayed.
    • The originating financial institution may charge a wire transfer fee. If the financial institution charges a wire transfer fee it is required that you add that amount to the payment to ensure that the invoice is paid in full.

    Use the following account information when sending a wire transfer: U.S. Department of the Treasury, TREAS NYC, 33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing No. 021030004, SWIFT: FRNYUS33.

    FDA records the official application receipt date as the later of the following: (1) The date the application was received by the FDA Document Control Center for the reviewing Center or (2) the date the U.S. Treasury recognizes the payment. It is helpful if the fee arrives at the bank at least 1 day before the application arrives at FDA.

    D. Submit Your Application to FDA With a Copy of the Completed Medical Device User Fee Cover Sheet

    Please submit your application and a copy of the completed Medical Device User Fee cover sheet to the address located at https://www.fda.gov/​cdrhsubmissionaddress. Start Printed Page 41482

    VI. Procedures for Paying the Annual Fee for Periodic Reporting

    You will be invoiced at the end of the quarter in which your PMA Periodic Report is due. Invoices will be sent based on the details included on your PMA file. You are responsible for ensuring FDA has your current billing information, and you may update your contact information for the PMA by submitting an amendment to the pending PMA or a supplement to the approved PMA.

    1. The preferred payment method is online using electronic check (ACH also known as eCheck) or credit card (Discover, VISA, MasterCard, American Express). Secure electronic payments can be submitted using the User Fees Payment Portal at https://userfees.fda.gov/​pay (Note: only full payments are accepted. No partial payments can be made online). Once you search for your invoice, select “Pay Now” to be redirected to Pay.gov. Note that electronic payment options are based on the balance due. Payment by credit card is available for balances that are less than $25,000. If the balance exceeds this amount, only the ACH option is available. Payments must be made using U.S. bank accounts as well as U.S. credit cards.

    2. If paying with a paper check:

    The check must be in U.S. currency from a U.S. bank and made payable to the Food and Drug Administration. If needed, FDA's tax identification number is 53-0196965.

    • Please write your invoice number on the check.
    • Mail the paper check and a copy of the invoice to: Food and Drug Administration, P.O. Box 979033, St. Louis, MO 63197-9000. (Please note that this address is for payments of application and annual report fees only and is not to be used for payment of annual establishment registration fees.)

    To send a check by a courier, the courier must deliver the check and printed copy of the cover sheet to: U.S. Bank, Attn: Government Lockbox 979033, 1005 Convention Plaza, St. Louis, MO 63101. (Note: This U.S. Bank address is for courier delivery only. If you have any questions concerning courier delivery, contact U.S. Bank at 314-418-4013. This telephone number is only for questions about courier delivery).

    3. When paying by a wire transfer, it is required that the invoice number is included; without the invoice number the payment may not be applied. If the payment amount is not applied, the invoice amount would be referred to collections. The originating financial institution may charge a wire transfer fee. If the financial institution charges a wire transfer fee, it is required that you add that amount to the payment to ensure that the invoice is paid in full.

    Use the following account information when sending a wire transfer: U.S. Department of the Treasury, TREAS NYC, 33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing No. 021030004, SWIFT: FRNYUS33.

    VII. Procedures for Paying Annual Establishment Registration Fees

    To pay the annual establishment registration fee, firms must access the Device Facility User Fee (DFUF) website at https://userfees.fda.gov/​OA_​HTML/​furls.jsp. (FDA has verified the website address, but FDA is not responsible for any subsequent changes to the website address after this document publishes in the Federal Register.) Create a DFUF order and you will be issued a PIN when you place your order. After payment has been processed, you will be issued a payment confirmation number (PCN). You will not be able to register your establishment if you do not have a PIN and a PCN. An establishment required to pay an annual establishment registration fee is not legally registered in FY 2022 until it has completed the steps below to register and pay any applicable fee (see 21 U.S.C. 379j(f)(2)).

    Companies that do not manufacture any product other than a licensed biologic are required to register in the Blood Establishment Registration (BER) system. FDA's Center for Biologics Evaluation and Research (CBER) will send establishment registration fee invoices annually to these companies.

    A. Submit a DFUF Order With a PIN From FDA Before Registering or Submitting Payment

    To submit a DFUF Order, you must create or have previously created a user account and password for the user fee website listed previously in this section. After creating a user name and password, log into the Establishment Registration User Fee FY 2022 store. Complete the DFUF order by entering the number of establishments you are registering that require payment. When you are satisfied that the information in the order is accurate, electronically transmit that data to FDA according to instructions on the screen. Print a copy of the final DFUF order and note the unique PIN located in the upper right-hand corner of the printed order.

    B. Pay for Your DFUF Order

    Unless paying by U.S. credit card, all payments must be in U. S. currency and drawn on a U.S. bank.

    1. If paying by credit card or electronic check (ACH or eCheck):

    The DFUF order will include payment information, including details on how you can pay online using a credit card or electronic check. Follow the instructions provided to make an electronic payment.

    2. If paying with a paper check:

    The check must be in U.S. currency and drawn on a U.S. bank, and mailed to: Food and Drug Administration, P.O. Box 979108, St. Louis, MO 63197-9000. (Note: This address is different from the address for payments of application and annual report fees and is to be used only for payment of annual establishment registration fees.)

    If a check is sent by a courier that requests a street address, the courier can deliver the check to: U.S. Bank, Attn: Government Lockbox 979108, 1005 Convention Plaza, St. Louis, MO 63101. (Note: This U.S. Bank address is for courier delivery only. If you have any questions concerning courier delivery, contact U.S. Bank at 314-418-4013. This telephone number is only for questions about courier delivery.)

    Please make sure that both of the following are written on your check: (1) The FDA post office box number (P.O. Box 979108) and (2) the PIN that is printed on your order. Include a copy of your printed order when you mail your check.

    3. If paying with a wire transfer:

    Wire transfers may also be used to pay annual establishment registration fees. To send a wire transfer, please read and comply with the following information:

    Include your order's unique PIN (in the upper right-hand corner of your completed DFUF order) in your wire transfer. Without the PIN, your payment may not be applied to your facility and your registration may be delayed.

    The originating financial institution may charge a wire transfer fee. If the financial institution charges a wire transfer fee, it is required that you add that amount to the payment to ensure that the invoice is paid in full. Use the following account information when sending a wire transfer: U.S. Dept. of the Treasury, TREAS NYC, 33 Liberty St., New York, NY 10045, Acct. No. 75060099, Routing No. 021030004, SWIFT: FRNYUS33. If needed, FDA's tax identification number is 53-0196965.Start Printed Page 41483

    C. Complete the Information Online To Update Your Establishment's Annual Registration for FY 2022, or To Register a New Establishment for FY 2022

    Go to the Center for Devices and Radiological Health's website at https://www.fda.gov/​medical-devices/​how-study-and-market-your-device/​device-registration-and-listing and click the “Access Electronic Registration” link on the left side of the page. This opens up a new page with important information about the FDA Unified Registration and Listing System (FURLS). After reading this information, click on the “Access Electronic Registration” link in the middle of the page. This link takes you to an FDA Industry Systems page with tutorials that demonstrate how to create a new FURLS user account, if your establishment did not create an account in FY 2021. Manufacturers of licensed biologics should register in the BER system at https://www.fda.gov/​vaccines-blood-biologics/​guidance-compliance-regulatory-information-biologics/​biologics-establishment-registration.

    Enter your existing account ID and password to log into FURLS. From the FURLS/FDA Industry Systems menu, click on the Device Registration and Listing Module (DRLM) of FURLS button. New establishments will need to register and existing establishments will update their annual registration using choices on the DRLM menu. When you choose to register or update your annual registration, the system will prompt you through the entry of information about your establishment and your devices. If you have any problems with this process, email: reglist@cdrh.fda.gov or call 301-796-7400 for assistance. (Note: This email address and this telephone number are for assistance with establishment registration only; they are not to be used for questions related to other aspects of medical device user fees.) Problems with the BER system should be directed to https://www.accessdata.fda.gov/​scripts/​email/​cber/​bldregcontact.cfm or call 240-402-8360.

    D. Enter Your DFUF Order PIN and PCN

    After completing your annual or initial registration and device listing, you will be prompted to enter your DFUF order PIN and PCN, when applicable. This process does not apply to establishments engaged only in the manufacture, preparation, propagation, compounding, or processing of licensed biologic devices. CBER will send invoices for payment of the establishment registration fee to such establishments.

    Start Signature

    Dated: July 28, 2021.

    Lauren K. Roth,

    Acting Principal Associate Commissioner for Policy.

    End Signature End Supplemental Information

    Footnotes

    1.  The Bureau of Labor Statistics' Announcement of the geographical revision can be viewed at https://www.bls.gov/​cpi/​additional-resources/​geographic-revision-2018.htm.

    Back to Citation

    [FR Doc. 2021-16408 Filed 7-30-21; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
08/02/2021
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2021-16408
Pages:
41477-41483 (7 pages)
Docket Numbers:
Docket No. FDA-2021-N-0659
PDF File:
2021-16408.pdf
Supporting Documents:
» Medical Device User Fee Rates for Fiscal Year 2022